question
stringlengths
47
751
answer
stringlengths
4
183
slide_id
stringlengths
23
23
project
stringclasses
1 value
f1024
stringlengths
139
139
f2048
stringlengths
138
138
f4096
stringlengths
139
139
what is the histologic grade of the invasive carcinoma? A. grade 2 B. grade 3 C. grade 1 D. not specified
D. not specified
TCGA-EW-A1P5-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P5-01Z-00-DX1.B0D59A56-116E-48B3-BC90-237EA4B3F95B_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P5-01Z-00-DX1.B0D59A56-116E-48B3-BC90-237EA4B3F95B_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P5-01Z-00-DX1.B0D59A56-116E-48B3-BC90-237EA4B3F95B_1_1024.npy
is lymphovascular invasion present in the breast? A. yes B. no C. not mentioned D. pending
B. no
TCGA-EW-A1P5-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P5-01Z-00-DX1.B0D59A56-116E-48B3-BC90-237EA4B3F95B_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P5-01Z-00-DX1.B0D59A56-116E-48B3-BC90-237EA4B3F95B_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P5-01Z-00-DX1.B0D59A56-116E-48B3-BC90-237EA4B3F95B_1_1024.npy
which receptors are the tumor cells positive for? A. estrogen and progesterone B. her-2 C. keratin D. none of the above
A. estrogen and progesterone
TCGA-EW-A1P5-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P5-01Z-00-DX1.B0D59A56-116E-48B3-BC90-237EA4B3F95B_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P5-01Z-00-DX1.B0D59A56-116E-48B3-BC90-237EA4B3F95B_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P5-01Z-00-DX1.B0D59A56-116E-48B3-BC90-237EA4B3F95B_1_1024.npy
is dermal lymph-vascular invasion identified? A. yes B. no C. not mentioned D. pending
B. no
TCGA-EW-A1P5-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P5-01Z-00-DX1.B0D59A56-116E-48B3-BC90-237EA4B3F95B_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P5-01Z-00-DX1.B0D59A56-116E-48B3-BC90-237EA4B3F95B_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-EW-A1P5-01Z-00-DX1.B0D59A56-116E-48B3-BC90-237EA4B3F95B_1_1024.npy
what type of carcinoma did the patient have? A. infiltrating ductal carcinoma B. infiltrating lobular carcinoma C. ductal carcinoma in situ D. medullary carcinoma
A. infiltrating ductal carcinoma
TCGA-AR-A0TU-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TU-01Z-00-DX1.2CBBDDAB-C1DD-4205-A555-431542F9C069_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TU-01Z-00-DX1.2CBBDDAB-C1DD-4205-A555-431542F9C069_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TU-01Z-00-DX1.2CBBDDAB-C1DD-4205-A555-431542F9C069_1_1024.npy
what is the nottingham grade of the carcinoma? A. grade i B. grade ii C. grade iii D. grade iv
C. grade iii
TCGA-AR-A0TU-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TU-01Z-00-DX1.2CBBDDAB-C1DD-4205-A555-431542F9C069_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TU-01Z-00-DX1.2CBBDDAB-C1DD-4205-A555-431542F9C069_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TU-01Z-00-DX1.2CBBDDAB-C1DD-4205-A555-431542F9C069_1_1024.npy
what type of protein overexpression is negative? A. her2/neu B. brca1 C. tp53 D. egfr
A. her2/neu
TCGA-AR-A0TU-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TU-01Z-00-DX1.2CBBDDAB-C1DD-4205-A555-431542F9C069_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TU-01Z-00-DX1.2CBBDDAB-C1DD-4205-A555-431542F9C069_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TU-01Z-00-DX1.2CBBDDAB-C1DD-4205-A555-431542F9C069_1_1024.npy
were the er and pr tests fda-approved? A. yes B. no C. partially D. not indicated
B. no
TCGA-AR-A0TU-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TU-01Z-00-DX1.2CBBDDAB-C1DD-4205-A555-431542F9C069_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TU-01Z-00-DX1.2CBBDDAB-C1DD-4205-A555-431542F9C069_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TU-01Z-00-DX1.2CBBDDAB-C1DD-4205-A555-431542F9C069_1_1024.npy
what is the patient's gender? A. 43-year-old B. white female C. left femur fracture D. large breast mass
B. white female
TCGA-B6-A0I9-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A0I9-01Z-00-DX1.78E1D43A-507E-482E-B988-AF13B12B4497_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A0I9-01Z-00-DX1.78E1D43A-507E-482E-B988-AF13B12B4497_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A0I9-01Z-00-DX1.78E1D43A-507E-482E-B988-AF13B12B4497_1_1024.npy
what is the suspected diagnosis of the breast mass? A. metastatic breast cancer B. intraductal carcinoma C. moderately differentiated carcinoma D. vascular invasion by carcinoma
A. metastatic breast cancer
TCGA-B6-A0I9-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A0I9-01Z-00-DX1.78E1D43A-507E-482E-B988-AF13B12B4497_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A0I9-01Z-00-DX1.78E1D43A-507E-482E-B988-AF13B12B4497_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A0I9-01Z-00-DX1.78E1D43A-507E-482E-B988-AF13B12B4497_1_1024.npy
what types of carcinoma were present in the biopsy? A. infiltrating duct carcinoma B. solid and comedo types C. vascular invasion by carcinoma D. moderately differentiated carcinoma
B. solid and comedo types
TCGA-B6-A0I9-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A0I9-01Z-00-DX1.78E1D43A-507E-482E-B988-AF13B12B4497_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A0I9-01Z-00-DX1.78E1D43A-507E-482E-B988-AF13B12B4497_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A0I9-01Z-00-DX1.78E1D43A-507E-482E-B988-AF13B12B4497_1_1024.npy
what was the nuclear grade of the carcinoma? A. moderately differentiated B. suspected to be metastatic C. 43-year-old D. left femur fracture
A. moderately differentiated
TCGA-B6-A0I9-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A0I9-01Z-00-DX1.78E1D43A-507E-482E-B988-AF13B12B4497_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A0I9-01Z-00-DX1.78E1D43A-507E-482E-B988-AF13B12B4497_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A0I9-01Z-00-DX1.78E1D43A-507E-482E-B988-AF13B12B4497_1_1024.npy
what other feature was identified in the biopsy? A. left femur fracture B. yellow fibro-adipose tissue C. vascular invasion by carcinoma D. infiltrating duct carcinoma
C. vascular invasion by carcinoma
TCGA-B6-A0I9-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A0I9-01Z-00-DX1.78E1D43A-507E-482E-B988-AF13B12B4497_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A0I9-01Z-00-DX1.78E1D43A-507E-482E-B988-AF13B12B4497_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-B6-A0I9-01Z-00-DX1.78E1D43A-507E-482E-B988-AF13B12B4497_1_1024.npy
when was the procedure performed? A. before the slide was written B. after the slide was written C. on the first day of the investigation D. on the second day of the investigation
A. before the slide was written
TCGA-BH-A1FJ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FJ-01Z-00-DX1.BCED4CEF-2B33-45BA-ABC7-29BEE818F4A3_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FJ-01Z-00-DX1.BCED4CEF-2B33-45BA-ABC7-29BEE818F4A3_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FJ-01Z-00-DX1.BCED4CEF-2B33-45BA-ABC7-29BEE818F4A3_1_1024.npy
what did the slide indicate about the nature of the potential tumor? A. benign B. unknown C. aggressively advancing D. cancerous
D. cancerous
TCGA-BH-A1FJ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FJ-01Z-00-DX1.BCED4CEF-2B33-45BA-ABC7-29BEE818F4A3_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FJ-01Z-00-DX1.BCED4CEF-2B33-45BA-ABC7-29BEE818F4A3_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FJ-01Z-00-DX1.BCED4CEF-2B33-45BA-ABC7-29BEE818F4A3_1_1024.npy
what is recommended in the slide regarding the investigation of the vascular space? A. no further investigation is necessary B. further investigate the vascular space C. ignore the potential tumor D. proceed with aggressive treatment immediately
B. further investigate the vascular space
TCGA-BH-A1FJ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FJ-01Z-00-DX1.BCED4CEF-2B33-45BA-ABC7-29BEE818F4A3_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FJ-01Z-00-DX1.BCED4CEF-2B33-45BA-ABC7-29BEE818F4A3_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FJ-01Z-00-DX1.BCED4CEF-2B33-45BA-ABC7-29BEE818F4A3_1_1024.npy
what is the status of the tumor's advancement according to the slide? A. advancing aggressively B. not aggressively advancing C. unknown D. in remission
B. not aggressively advancing
TCGA-BH-A1FJ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FJ-01Z-00-DX1.BCED4CEF-2B33-45BA-ABC7-29BEE818F4A3_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FJ-01Z-00-DX1.BCED4CEF-2B33-45BA-ABC7-29BEE818F4A3_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FJ-01Z-00-DX1.BCED4CEF-2B33-45BA-ABC7-29BEE818F4A3_1_1024.npy
what is mentioned about the margins of the tumor in the slide? A. unclear margins B. no information provided C. clear margins D. potentially dangerous margins
C. clear margins
TCGA-BH-A1FJ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FJ-01Z-00-DX1.BCED4CEF-2B33-45BA-ABC7-29BEE818F4A3_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FJ-01Z-00-DX1.BCED4CEF-2B33-45BA-ABC7-29BEE818F4A3_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FJ-01Z-00-DX1.BCED4CEF-2B33-45BA-ABC7-29BEE818F4A3_1_1024.npy
what is the result of the immunohistochemistry staining for estrogen receptor (er)? A. negative B. 1+ C. 3+ D. indeterminate
C. 3+
TCGA-E9-A54Y-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A54Y-01Z-00-DX1.5FD70369-6514-4E5E-8BEF-65DAC5671E1A_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A54Y-01Z-00-DX1.5FD70369-6514-4E5E-8BEF-65DAC5671E1A_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A54Y-01Z-00-DX1.5FD70369-6514-4E5E-8BEF-65DAC5671E1A_1_1024.npy
what is the result of the immunohistochemistry staining for her-2/neu? A. negative B. 1+ C. 3+ D. indeterminate
A. negative
TCGA-E9-A54Y-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A54Y-01Z-00-DX1.5FD70369-6514-4E5E-8BEF-65DAC5671E1A_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A54Y-01Z-00-DX1.5FD70369-6514-4E5E-8BEF-65DAC5671E1A_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A54Y-01Z-00-DX1.5FD70369-6514-4E5E-8BEF-65DAC5671E1A_1_1024.npy
what is the tumor size classification based on the tnm system? A. t0 B. t1 C. t2 D. t3
C. t2
TCGA-E9-A54Y-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A54Y-01Z-00-DX1.5FD70369-6514-4E5E-8BEF-65DAC5671E1A_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A54Y-01Z-00-DX1.5FD70369-6514-4E5E-8BEF-65DAC5671E1A_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-E9-A54Y-01Z-00-DX1.5FD70369-6514-4E5E-8BEF-65DAC5671E1A_1_1024.npy
what is found in the thyroid lobectomy? A. follicular adenoma B. proliferative fibrocystic changes C. invasive lobular carcinoma D. non-neoplastic breast tissue
A. follicular adenoma
TCGA-AR-A5QN-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QN-01Z-00-DX1.BF92AA24-3D44-4FFA-BCC0-CDB934EC3BBC_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QN-01Z-00-DX1.BF92AA24-3D44-4FFA-BCC0-CDB934EC3BBC_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QN-01Z-00-DX1.BF92AA24-3D44-4FFA-BCC0-CDB934EC3BBC_1_1024.npy
what is found in the breast at the previous biopsy site? A. invasive lobular carcinoma B. fibroadenoma C. nonproliferative fibrocystic changes D. metastatic carcinoma
A. invasive lobular carcinoma
TCGA-AR-A5QN-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QN-01Z-00-DX1.BF92AA24-3D44-4FFA-BCC0-CDB934EC3BBC_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QN-01Z-00-DX1.BF92AA24-3D44-4FFA-BCC0-CDB934EC3BBC_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QN-01Z-00-DX1.BF92AA24-3D44-4FFA-BCC0-CDB934EC3BBC_1_1024.npy
what is the grade of the invasive lobular carcinoma in the breast? A. nottingham grade i B. nottingham grade ii C. nottingham grade iii D. lobular carcinoma in situ
B. nottingham grade ii
TCGA-AR-A5QN-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QN-01Z-00-DX1.BF92AA24-3D44-4FFA-BCC0-CDB934EC3BBC_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QN-01Z-00-DX1.BF92AA24-3D44-4FFA-BCC0-CDB934EC3BBC_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QN-01Z-00-DX1.BF92AA24-3D44-4FFA-BCC0-CDB934EC3BBC_1_1024.npy
which areas of the breast show multiple masses? A. inferior flap and new inferior margin B. nipple and overlying skin C. axillary lymph nodes D. various locations within the breast
D. various locations within the breast
TCGA-AR-A5QN-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QN-01Z-00-DX1.BF92AA24-3D44-4FFA-BCC0-CDB934EC3BBC_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QN-01Z-00-DX1.BF92AA24-3D44-4FFA-BCC0-CDB934EC3BBC_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QN-01Z-00-DX1.BF92AA24-3D44-4FFA-BCC0-CDB934EC3BBC_1_1024.npy
what is the result of surgical resection margins in relation to invasive carcinoma? A. negative B. positive C. inconclusive D. cannot be determined
A. negative
TCGA-AR-A5QN-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QN-01Z-00-DX1.BF92AA24-3D44-4FFA-BCC0-CDB934EC3BBC_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QN-01Z-00-DX1.BF92AA24-3D44-4FFA-BCC0-CDB934EC3BBC_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A5QN-01Z-00-DX1.BF92AA24-3D44-4FFA-BCC0-CDB934EC3BBC_1_1024.npy
what type of cancer was found in the patient's breast? A. benign tumor B. infiltrating lobular carcinoma C. ductal carcinoma D. sarcoma
B. infiltrating lobular carcinoma
TCGA-A2-A1G4-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A1G4-01Z-00-DX1.0274DF5B-5920-419A-B778-2F04D9C602F2_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A1G4-01Z-00-DX1.0274DF5B-5920-419A-B778-2F04D9C602F2_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A1G4-01Z-00-DX1.0274DF5B-5920-419A-B778-2F04D9C602F2_1_1024.npy
what were the receptor status of the tumor? A. negative B. positive for estrogen receptor and progesterone receptor C. positive for her2 D. positive for insulin receptor
B. positive for estrogen receptor and progesterone receptor
TCGA-A2-A1G4-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A1G4-01Z-00-DX1.0274DF5B-5920-419A-B778-2F04D9C602F2_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A1G4-01Z-00-DX1.0274DF5B-5920-419A-B778-2F04D9C602F2_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A1G4-01Z-00-DX1.0274DF5B-5920-419A-B778-2F04D9C602F2_1_1024.npy
what index of the tumor was included in the slide? A. p53 index B. c-myc index C. ki67 index D. rb index
C. ki67 index
TCGA-A2-A1G4-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A1G4-01Z-00-DX1.0274DF5B-5920-419A-B778-2F04D9C602F2_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A1G4-01Z-00-DX1.0274DF5B-5920-419A-B778-2F04D9C602F2_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A1G4-01Z-00-DX1.0274DF5B-5920-419A-B778-2F04D9C602F2_1_1024.npy
how was the patient diagnosed with breast cancer? A. modified radical mastectomy B. subareolar and nipple lymphatics involvement C. lymph node metastasis D. tumor modules in the lymph nodes
D. tumor modules in the lymph nodes
TCGA-BH-A1F8-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1F8-01Z-00-DX1.8BB026F7-35CB-483F-B665-4C3A3EF47E1B_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1F8-01Z-00-DX1.8BB026F7-35CB-483F-B665-4C3A3EF47E1B_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1F8-01Z-00-DX1.8BB026F7-35CB-483F-B665-4C3A3EF47E1B_1_1024.npy
what is the grade of the tumor? A. grade 3 B. grade 2 C. grade 1 D. well differentiated
D. well differentiated
TCGA-BH-A1F8-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1F8-01Z-00-DX1.8BB026F7-35CB-483F-B665-4C3A3EF47E1B_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1F8-01Z-00-DX1.8BB026F7-35CB-483F-B665-4C3A3EF47E1B_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1F8-01Z-00-DX1.8BB026F7-35CB-483F-B665-4C3A3EF47E1B_1_1024.npy
what procedure was performed on the patient? A. procurement of the left axilla B. modified radical mastectomy C. subareolar and nipple lymphatics involvement D. tumor modules in the lymph nodes
D. tumor modules in the lymph nodes
TCGA-BH-A1F8-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1F8-01Z-00-DX1.8BB026F7-35CB-483F-B665-4C3A3EF47E1B_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1F8-01Z-00-DX1.8BB026F7-35CB-483F-B665-4C3A3EF47E1B_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1F8-01Z-00-DX1.8BB026F7-35CB-483F-B665-4C3A3EF47E1B_1_1024.npy
what is the differentiation status of the tumor? A. poorly differentiated B. well differentiated C. moderately differentiated D. tumor modules in the lymph nodes
D. tumor modules in the lymph nodes
TCGA-BH-A1F8-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1F8-01Z-00-DX1.8BB026F7-35CB-483F-B665-4C3A3EF47E1B_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1F8-01Z-00-DX1.8BB026F7-35CB-483F-B665-4C3A3EF47E1B_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1F8-01Z-00-DX1.8BB026F7-35CB-483F-B665-4C3A3EF47E1B_1_1024.npy
what type of breast cancer did the patient have? A. invasive lobular carcinoma B. invasive ductal carcinoma C. ductal carcinoma in situ D. metastatic carcinoma
B. invasive ductal carcinoma
TCGA-A7-A4SE-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SE-01Z-00-DX1.16BC8401-E40E-4A1A-9BD9-12735C9AE3F6_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SE-01Z-00-DX1.16BC8401-E40E-4A1A-9BD9-12735C9AE3F6_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SE-01Z-00-DX1.16BC8401-E40E-4A1A-9BD9-12735C9AE3F6_1_1024.npy
what was the grade of the cancer? A. grade 1 B. grade 2 C. grade 3 D. grade 4
C. grade 3
TCGA-A7-A4SE-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SE-01Z-00-DX1.16BC8401-E40E-4A1A-9BD9-12735C9AE3F6_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SE-01Z-00-DX1.16BC8401-E40E-4A1A-9BD9-12735C9AE3F6_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SE-01Z-00-DX1.16BC8401-E40E-4A1A-9BD9-12735C9AE3F6_1_1024.npy
were the margins of excision positive or negative? A. positive B. negative C. inconclusive D. unclear
B. negative
TCGA-A7-A4SE-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SE-01Z-00-DX1.16BC8401-E40E-4A1A-9BD9-12735C9AE3F6_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SE-01Z-00-DX1.16BC8401-E40E-4A1A-9BD9-12735C9AE3F6_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SE-01Z-00-DX1.16BC8401-E40E-4A1A-9BD9-12735C9AE3F6_1_1024.npy
was vessel invasion identified in the tumor? A. yes, vessel invasion was identified B. no, vessel invasion was not identified C. inconclusive D. unclear
B. no, vessel invasion was not identified
TCGA-A7-A4SE-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SE-01Z-00-DX1.16BC8401-E40E-4A1A-9BD9-12735C9AE3F6_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SE-01Z-00-DX1.16BC8401-E40E-4A1A-9BD9-12735C9AE3F6_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A7-A4SE-01Z-00-DX1.16BC8401-E40E-4A1A-9BD9-12735C9AE3F6_1_1024.npy
what type of breast cancer has the patient been diagnosed with? A. paget's disease B. ductal carcinoma in situ C. infiltrative ductal carcinoma D. lobular carcinoma
C. infiltrative ductal carcinoma
TCGA-AN-A0XO-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XO-01Z-00-DX1.204E554E-B1A8-41AD-8E39-62484DF4E3CD_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XO-01Z-00-DX1.204E554E-B1A8-41AD-8E39-62484DF4E3CD_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XO-01Z-00-DX1.204E554E-B1A8-41AD-8E39-62484DF4E3CD_1_1024.npy
what is the grade of the tumor? A. grade 1 B. grade 2 C. grade 3 D. grade 4
B. grade 2
TCGA-AN-A0XO-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XO-01Z-00-DX1.204E554E-B1A8-41AD-8E39-62484DF4E3CD_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XO-01Z-00-DX1.204E554E-B1A8-41AD-8E39-62484DF4E3CD_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XO-01Z-00-DX1.204E554E-B1A8-41AD-8E39-62484DF4E3CD_1_1024.npy
what is the t stage of the tumor? A. t stage 0 B. t stage 1 C. t stage 2 D. t stage 3
C. t stage 2
TCGA-AN-A0XO-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XO-01Z-00-DX1.204E554E-B1A8-41AD-8E39-62484DF4E3CD_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XO-01Z-00-DX1.204E554E-B1A8-41AD-8E39-62484DF4E3CD_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XO-01Z-00-DX1.204E554E-B1A8-41AD-8E39-62484DF4E3CD_1_1024.npy
what is the n stage of the tumor? A. n stage 0 B. n stage 1 C. n stage 2 D. n stage 3
B. n stage 1
TCGA-AN-A0XO-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XO-01Z-00-DX1.204E554E-B1A8-41AD-8E39-62484DF4E3CD_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XO-01Z-00-DX1.204E554E-B1A8-41AD-8E39-62484DF4E3CD_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XO-01Z-00-DX1.204E554E-B1A8-41AD-8E39-62484DF4E3CD_1_1024.npy
what is the m stage of the tumor? A. m stage 0 B. m stage 1 C. m stage 2 D. m stage 3
A. m stage 0
TCGA-AN-A0XO-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XO-01Z-00-DX1.204E554E-B1A8-41AD-8E39-62484DF4E3CD_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XO-01Z-00-DX1.204E554E-B1A8-41AD-8E39-62484DF4E3CD_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XO-01Z-00-DX1.204E554E-B1A8-41AD-8E39-62484DF4E3CD_1_1024.npy
has the patient received any treatment? A. yes B. no C. unknown D. not mentioned
B. no
TCGA-AN-A0XO-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XO-01Z-00-DX1.204E554E-B1A8-41AD-8E39-62484DF4E3CD_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XO-01Z-00-DX1.204E554E-B1A8-41AD-8E39-62484DF4E3CD_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AN-A0XO-01Z-00-DX1.204E554E-B1A8-41AD-8E39-62484DF4E3CD_1_1024.npy
which type of carcinoma was found in the patient's breast? A. invasive ductal carcinoma B. invasive lobular carcinoma C. ductal carcinoma in situ D. papillary carcinoma
A. invasive ductal carcinoma
TCGA-GM-A2DH-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A2DH-01Z-00-DX1.5790F15F-2A0F-4929-8FE4-18A557007989_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A2DH-01Z-00-DX1.5790F15F-2A0F-4929-8FE4-18A557007989_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A2DH-01Z-00-DX1.5790F15F-2A0F-4929-8FE4-18A557007989_1_1024.npy
what grade was given to the histologic assessment of the tumor? A. grade 1 B. grade 2 C. grade 3 D. grade 4
C. grade 3
TCGA-GM-A2DH-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A2DH-01Z-00-DX1.5790F15F-2A0F-4929-8FE4-18A557007989_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A2DH-01Z-00-DX1.5790F15F-2A0F-4929-8FE4-18A557007989_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A2DH-01Z-00-DX1.5790F15F-2A0F-4929-8FE4-18A557007989_1_1024.npy
what additional testing is required to assess hormone receptor status and her2 gene copy level? A. blood test B. bone scan C. pet scan D. further testing
D. further testing
TCGA-GM-A2DH-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A2DH-01Z-00-DX1.5790F15F-2A0F-4929-8FE4-18A557007989_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A2DH-01Z-00-DX1.5790F15F-2A0F-4929-8FE4-18A557007989_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A2DH-01Z-00-DX1.5790F15F-2A0F-4929-8FE4-18A557007989_1_1024.npy
what other conditions were present alongside the invasive ductal carcinoma? A. lymphocytic infiltrate B. adjacent columnar cell hyperplasia and calcifications C. dcis D. intralymphatic tumor
B. adjacent columnar cell hyperplasia and calcifications
TCGA-GM-A2DH-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A2DH-01Z-00-DX1.5790F15F-2A0F-4929-8FE4-18A557007989_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A2DH-01Z-00-DX1.5790F15F-2A0F-4929-8FE4-18A557007989_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A2DH-01Z-00-DX1.5790F15F-2A0F-4929-8FE4-18A557007989_1_1024.npy
what was the grade of the breast tumor? A. grade i B. grade ii C. grade iii D. grade iv
C. grade iii
TCGA-HN-A2NL-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-HN-A2NL-01Z-00-DX1.C2EAF378-4B37-4C1C-BB0F-18FAC62EEC13_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-HN-A2NL-01Z-00-DX1.C2EAF378-4B37-4C1C-BB0F-18FAC62EEC13_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-HN-A2NL-01Z-00-DX1.C2EAF378-4B37-4C1C-BB0F-18FAC62EEC13_1_1024.npy
what were the er, pr, and her2 statuses of the tumor? A. er+, pr+, her2- B. er-, pr+, her2+ C. er+, pr-, her2+ D. er-, pr-, her2-
D. er-, pr-, her2-
TCGA-HN-A2NL-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-HN-A2NL-01Z-00-DX1.C2EAF378-4B37-4C1C-BB0F-18FAC62EEC13_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-HN-A2NL-01Z-00-DX1.C2EAF378-4B37-4C1C-BB0F-18FAC62EEC13_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-HN-A2NL-01Z-00-DX1.C2EAF378-4B37-4C1C-BB0F-18FAC62EEC13_1_1024.npy
was in situ carcinoma found in the tumor? A. yes B. no C. not mentioned D. cannot be determined
B. no
TCGA-HN-A2NL-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-HN-A2NL-01Z-00-DX1.C2EAF378-4B37-4C1C-BB0F-18FAC62EEC13_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-HN-A2NL-01Z-00-DX1.C2EAF378-4B37-4C1C-BB0F-18FAC62EEC13_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-HN-A2NL-01Z-00-DX1.C2EAF378-4B37-4C1C-BB0F-18FAC62EEC13_1_1024.npy
which breast was affected by the tumor? A. right breast B. left breast C. both breasts D. cannot be determined
B. left breast
TCGA-HN-A2NL-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-HN-A2NL-01Z-00-DX1.C2EAF378-4B37-4C1C-BB0F-18FAC62EEC13_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-HN-A2NL-01Z-00-DX1.C2EAF378-4B37-4C1C-BB0F-18FAC62EEC13_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-HN-A2NL-01Z-00-DX1.C2EAF378-4B37-4C1C-BB0F-18FAC62EEC13_1_1024.npy
how many other masses were identified in the specimen? A. none. B. one. C. two. D. not mentioned.
A. none.
TCGA-AC-A2B8-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A2B8-01Z-00-DX1.14F3A9B2-1382-436A-B53C-92FC8495AD48_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A2B8-01Z-00-DX1.14F3A9B2-1382-436A-B53C-92FC8495AD48_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A2B8-01Z-00-DX1.14F3A9B2-1382-436A-B53C-92FC8495AD48_1_1024.npy
what were the findings of the microscopic examination of the sentinel node? A. malignant cells. B. benign cells. C. inconclusive. D. not mentioned.
B. benign cells.
TCGA-AC-A2B8-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A2B8-01Z-00-DX1.14F3A9B2-1382-436A-B53C-92FC8495AD48_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A2B8-01Z-00-DX1.14F3A9B2-1382-436A-B53C-92FC8495AD48_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A2B8-01Z-00-DX1.14F3A9B2-1382-436A-B53C-92FC8495AD48_1_1024.npy
what was the final breast tumor classification? A. t2pno (+) mx. B. t4pno (+) mx. C. t3pno (+) mx. D. not mentioned.
C. t3pno (+) mx.
TCGA-AC-A2B8-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A2B8-01Z-00-DX1.14F3A9B2-1382-436A-B53C-92FC8495AD48_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A2B8-01Z-00-DX1.14F3A9B2-1382-436A-B53C-92FC8495AD48_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AC-A2B8-01Z-00-DX1.14F3A9B2-1382-436A-B53C-92FC8495AD48_1_1024.npy
was there lymphovascular and perineural invasion present in the breast tissue? A. yes, there was B. no, there was not C. the slide did not indicate D. the slide is inconclusive
A. yes, there was
TCGA-S3-A6ZG-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-A6ZG-01Z-00-DX1.659A0BFB-D99B-474F-B4C2-6590C9161BD1_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-A6ZG-01Z-00-DX1.659A0BFB-D99B-474F-B4C2-6590C9161BD1_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-A6ZG-01Z-00-DX1.659A0BFB-D99B-474F-B4C2-6590C9161BD1_1_1024.npy
what grades of carcinoma were present in the breast tissue? A. grade 1 B. grade 2 C. grade 3 D. grade 4
B. grade 2
TCGA-S3-A6ZG-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-A6ZG-01Z-00-DX1.659A0BFB-D99B-474F-B4C2-6590C9161BD1_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-A6ZG-01Z-00-DX1.659A0BFB-D99B-474F-B4C2-6590C9161BD1_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-A6ZG-01Z-00-DX1.659A0BFB-D99B-474F-B4C2-6590C9161BD1_1_1024.npy
what types of carcinoma were present in the breast tissue? A. mixed ductal and lobular carcinoma B. invasive ductal carcinoma C. invasive lobular carcinoma D. the slide did not indicate
A. mixed ductal and lobular carcinoma
TCGA-S3-A6ZG-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-A6ZG-01Z-00-DX1.659A0BFB-D99B-474F-B4C2-6590C9161BD1_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-A6ZG-01Z-00-DX1.659A0BFB-D99B-474F-B4C2-6590C9161BD1_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-A6ZG-01Z-00-DX1.659A0BFB-D99B-474F-B4C2-6590C9161BD1_1_1024.npy
what additional findings were present in the breast tissue besides carcinoma? A. nodal involvement B. atypical ductal hyperplasia C. atypical lobular hyperplasia D. the slide did not indicate
C. atypical lobular hyperplasia
TCGA-S3-A6ZG-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-A6ZG-01Z-00-DX1.659A0BFB-D99B-474F-B4C2-6590C9161BD1_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-A6ZG-01Z-00-DX1.659A0BFB-D99B-474F-B4C2-6590C9161BD1_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-S3-A6ZG-01Z-00-DX1.659A0BFB-D99B-474F-B4C2-6590C9161BD1_1_1024.npy
what is the subtype of invasive ductal carcinoma in the breast? A. solid and cribriform B. squamous and papillary C. lobular and mucinous D. inflammatory and medullary
A. solid and cribriform
TCGA-BH-A0BJ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BJ-01Z-00-DX1.77BE9A20-3D23-4650-843A-0483BF9DD07B_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BJ-01Z-00-DX1.77BE9A20-3D23-4650-843A-0483BF9DD07B_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BJ-01Z-00-DX1.77BE9A20-3D23-4650-843A-0483BF9DD07B_1_1024.npy
what is the hormone receptor status of the tumor? A. estrogen receptor positive and progesterone receptor negative B. estrogen receptor negative and progesterone receptor positive C. estrogen receptor negative and progesterone receptor negative D. estrogen receptor positive and progesterone receptor positive
D. estrogen receptor positive and progesterone receptor positive
TCGA-BH-A0BJ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BJ-01Z-00-DX1.77BE9A20-3D23-4650-843A-0483BF9DD07B_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BJ-01Z-00-DX1.77BE9A20-3D23-4650-843A-0483BF9DD07B_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BJ-01Z-00-DX1.77BE9A20-3D23-4650-843A-0483BF9DD07B_1_1024.npy
what is the her2 status of the tumor? A. her2 positive B. her2 negative C. her2 equivocal D. her2 amplification not determined
B. her2 negative
TCGA-BH-A0BJ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BJ-01Z-00-DX1.77BE9A20-3D23-4650-843A-0483BF9DD07B_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BJ-01Z-00-DX1.77BE9A20-3D23-4650-843A-0483BF9DD07B_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BJ-01Z-00-DX1.77BE9A20-3D23-4650-843A-0483BF9DD07B_1_1024.npy
what is the status of the resection margins? A. tumor involvement at the margins B. clear margins C. unclear margins D. involvement of deep margins only
B. clear margins
TCGA-BH-A0BJ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BJ-01Z-00-DX1.77BE9A20-3D23-4650-843A-0483BF9DD07B_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BJ-01Z-00-DX1.77BE9A20-3D23-4650-843A-0483BF9DD07B_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0BJ-01Z-00-DX1.77BE9A20-3D23-4650-843A-0483BF9DD07B_1_1024.npy
in which breast was the papillary carcinoma found? A. right breast B. left breast C. both breasts D. no evidence of malignancy.
B. left breast
TCGA-A2-A0CQ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CQ-01Z-00-DX1.4E5FB4E5-A08C-4C87-A3BE-0640A95AE649_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CQ-01Z-00-DX1.4E5FB4E5-A08C-4C87-A3BE-0640A95AE649_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CQ-01Z-00-DX1.4E5FB4E5-A08C-4C87-A3BE-0640A95AE649_1_1024.npy
which type of carcinoma is present in the breast lumpectomy? A. papillary carcinoma B. ductal carcinoma C. infiltrating ductal adenocarcinoma D. lobular carcinoma in-situ
A. papillary carcinoma
TCGA-A2-A0CQ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CQ-01Z-00-DX1.4E5FB4E5-A08C-4C87-A3BE-0640A95AE649_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CQ-01Z-00-DX1.4E5FB4E5-A08C-4C87-A3BE-0640A95AE649_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CQ-01Z-00-DX1.4E5FB4E5-A08C-4C87-A3BE-0640A95AE649_1_1024.npy
what is the ajcc stage of the carcinoma? A. pt1 pno(i-) mx B. pt2 pno(i-) mx C. pt3 pno(i-) mx D. not mentioned.
A. pt1 pno(i-) mx
TCGA-A2-A0CQ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CQ-01Z-00-DX1.4E5FB4E5-A08C-4C87-A3BE-0640A95AE649_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CQ-01Z-00-DX1.4E5FB4E5-A08C-4C87-A3BE-0640A95AE649_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CQ-01Z-00-DX1.4E5FB4E5-A08C-4C87-A3BE-0640A95AE649_1_1024.npy
is invasive carcinoma present in the final superior margin excision? A. yes, it is. B. no, it isn't. C. in both breast lumpectomies. D. not mentioned.
B. no, it isn't.
TCGA-A2-A0CQ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CQ-01Z-00-DX1.4E5FB4E5-A08C-4C87-A3BE-0640A95AE649_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CQ-01Z-00-DX1.4E5FB4E5-A08C-4C87-A3BE-0640A95AE649_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A0CQ-01Z-00-DX1.4E5FB4E5-A08C-4C87-A3BE-0640A95AE649_1_1024.npy
what was the main reason for the surgery? A. invasive ductal carcinoma B. metastatic carcinoma C. ductal carcinoma in situ D. her2/neu status
A. invasive ductal carcinoma
TCGA-AR-A0TZ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TZ-01Z-00-DX1.2D58BE38-03F6-4310-8E06-F1A523FB0904_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TZ-01Z-00-DX1.2D58BE38-03F6-4310-8E06-F1A523FB0904_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TZ-01Z-00-DX1.2D58BE38-03F6-4310-8E06-F1A523FB0904_1_1024.npy
where was the largest mass found? A. upper inner quadrant B. upper outer quadrant C. lower inner quadrant D. lower outer quadrant
B. upper outer quadrant
TCGA-AR-A0TZ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TZ-01Z-00-DX1.2D58BE38-03F6-4310-8E06-F1A523FB0904_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TZ-01Z-00-DX1.2D58BE38-03F6-4310-8E06-F1A523FB0904_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TZ-01Z-00-DX1.2D58BE38-03F6-4310-8E06-F1A523FB0904_1_1024.npy
what is the grade of the tumor? A. nottingham grade i B. nottingham grade ii C. nottingham grade iii D. nottingham grade iv
B. nottingham grade ii
TCGA-AR-A0TZ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TZ-01Z-00-DX1.2D58BE38-03F6-4310-8E06-F1A523FB0904_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TZ-01Z-00-DX1.2D58BE38-03F6-4310-8E06-F1A523FB0904_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TZ-01Z-00-DX1.2D58BE38-03F6-4310-8E06-F1A523FB0904_1_1024.npy
what part of the breast is free of neoplasm? A. skin B. nipple C. deep margin D. all of the above
D. all of the above
TCGA-AR-A0TZ-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TZ-01Z-00-DX1.2D58BE38-03F6-4310-8E06-F1A523FB0904_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TZ-01Z-00-DX1.2D58BE38-03F6-4310-8E06-F1A523FB0904_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A0TZ-01Z-00-DX1.2D58BE38-03F6-4310-8E06-F1A523FB0904_1_1024.npy
what type of cancer did the patient have in their breast? A. ductal carcinoma B. inflammatory breast cancer C. lobular carcinoma D. sarcoma
A. ductal carcinoma
TCGA-A2-A3XX-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XX-01Z-00-DX1.03C6D70F-2833-4E97-91B7-DE70CD083D92_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XX-01Z-00-DX1.03C6D70F-2833-4E97-91B7-DE70CD083D92_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XX-01Z-00-DX1.03C6D70F-2833-4E97-91B7-DE70CD083D92_1_1024.npy
what was the grade of the infiltrating ductal carcinoma? A. grade 1 out of 3. B. grade 2 out of 3. C. grade 3 out of 3. D. no grade was given.
C. grade 3 out of 3.
TCGA-A2-A3XX-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XX-01Z-00-DX1.03C6D70F-2833-4E97-91B7-DE70CD083D92_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XX-01Z-00-DX1.03C6D70F-2833-4E97-91B7-DE70CD083D92_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XX-01Z-00-DX1.03C6D70F-2833-4E97-91B7-DE70CD083D92_1_1024.npy
what was the receptor status of the tumor? A. positive for estrogen receptors and her2. B. negative for estrogen receptors and positive for her2. C. negative for estrogen receptors, negative for progesterone receptors, and negative for her2. D. positive for estrogen receptors, negative for progesterone receptors, and negative for her2.
C. negative for estrogen receptors, negative for progesterone receptors, and negative for her2.
TCGA-A2-A3XX-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XX-01Z-00-DX1.03C6D70F-2833-4E97-91B7-DE70CD083D92_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XX-01Z-00-DX1.03C6D70F-2833-4E97-91B7-DE70CD083D92_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XX-01Z-00-DX1.03C6D70F-2833-4E97-91B7-DE70CD083D92_1_1024.npy
what was the pathologic stage of the cancer? A. pt1 no(i-) mx. B. pt2 no(i-) mx. C. pt3 no(i-) mx. D. pt4 no(i-) mx.
B. pt2 no(i-) mx.
TCGA-A2-A3XX-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XX-01Z-00-DX1.03C6D70F-2833-4E97-91B7-DE70CD083D92_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XX-01Z-00-DX1.03C6D70F-2833-4E97-91B7-DE70CD083D92_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XX-01Z-00-DX1.03C6D70F-2833-4E97-91B7-DE70CD083D92_1_1024.npy
which regions had positive margins? A. superior and posterior B. inferior and anterior C. medial and posterior D. lateral and inferior
B. inferior and anterior
TCGA-A2-A3XT-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XT-01Z-00-DX1.336D6C78-576A-481B-8C83-F3A0FC4B182C_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XT-01Z-00-DX1.336D6C78-576A-481B-8C83-F3A0FC4B182C_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XT-01Z-00-DX1.336D6C78-576A-481B-8C83-F3A0FC4B182C_1_1024.npy
what was the grade of the adenocarcinoma found in the patient's breast? A. well differentiated B. moderately differentiated C. poorly differentiated D. undifferentiated
C. poorly differentiated
TCGA-A2-A3XT-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XT-01Z-00-DX1.336D6C78-576A-481B-8C83-F3A0FC4B182C_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XT-01Z-00-DX1.336D6C78-576A-481B-8C83-F3A0FC4B182C_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XT-01Z-00-DX1.336D6C78-576A-481B-8C83-F3A0FC4B182C_1_1024.npy
what was the result of the her2 immunohistochemistry testing? A. positive B. negative C. inconclusive D. not mentioned
B. negative
TCGA-A2-A3XT-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XT-01Z-00-DX1.336D6C78-576A-481B-8C83-F3A0FC4B182C_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XT-01Z-00-DX1.336D6C78-576A-481B-8C83-F3A0FC4B182C_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XT-01Z-00-DX1.336D6C78-576A-481B-8C83-F3A0FC4B182C_1_1024.npy
was an intraductal component identified? A. yes B. no C. inconclusive D. not mentioned
B. no
TCGA-A2-A3XT-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XT-01Z-00-DX1.336D6C78-576A-481B-8C83-F3A0FC4B182C_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XT-01Z-00-DX1.336D6C78-576A-481B-8C83-F3A0FC4B182C_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XT-01Z-00-DX1.336D6C78-576A-481B-8C83-F3A0FC4B182C_1_1024.npy
what was the instruction given in the slide about the breast primary origin? A. further stains were not needed B. further stains were needed C. primary origin was certain D. primary origin was inconclusive
B. further stains were needed
TCGA-A2-A3XT-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XT-01Z-00-DX1.336D6C78-576A-481B-8C83-F3A0FC4B182C_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XT-01Z-00-DX1.336D6C78-576A-481B-8C83-F3A0FC4B182C_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A3XT-01Z-00-DX1.336D6C78-576A-481B-8C83-F3A0FC4B182C_1_1024.npy
what was the type of breast cancer that the patient had? A. sarcoma B. inflammatory carcinoma C. infiltrating ductal carcinoma D. lobular carcinoma
C. infiltrating ductal carcinoma
TCGA-A2-A04Q-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A04Q-01Z-00-DX1.DF7ED6B6-7701-486D-9007-F26B6F0682C4_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A04Q-01Z-00-DX1.DF7ED6B6-7701-486D-9007-F26B6F0682C4_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A04Q-01Z-00-DX1.DF7ED6B6-7701-486D-9007-F26B6F0682C4_1_1024.npy
was the her2 neu amplified by fish? A. yes B. no C. insufficient data D. not mentioned in the slide
B. no
TCGA-A2-A04Q-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A04Q-01Z-00-DX1.DF7ED6B6-7701-486D-9007-F26B6F0682C4_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A04Q-01Z-00-DX1.DF7ED6B6-7701-486D-9007-F26B6F0682C4_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A04Q-01Z-00-DX1.DF7ED6B6-7701-486D-9007-F26B6F0682C4_1_1024.npy
were there any residual paget's disease or involvement of lactiferous ducts? A. yes, there was residual paget's disease B. yes, there was involvement of lactiferous ducts C. no, there were neither residual paget's disease nor involvement of lactiferous ducts D. insufficient data
C. no, there were neither residual paget's disease nor involvement of lactiferous ducts
TCGA-A2-A04Q-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A04Q-01Z-00-DX1.DF7ED6B6-7701-486D-9007-F26B6F0682C4_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A04Q-01Z-00-DX1.DF7ED6B6-7701-486D-9007-F26B6F0682C4_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A04Q-01Z-00-DX1.DF7ED6B6-7701-486D-9007-F26B6F0682C4_1_1024.npy
were the progesterone receptors positive or negative in both the infiltrating and in situ carcinoma? A. positive B. negative C. insufficient data D. not mentioned in the slide
B. negative
TCGA-A2-A04Q-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A04Q-01Z-00-DX1.DF7ED6B6-7701-486D-9007-F26B6F0682C4_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A04Q-01Z-00-DX1.DF7ED6B6-7701-486D-9007-F26B6F0682C4_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-A2-A04Q-01Z-00-DX1.DF7ED6B6-7701-486D-9007-F26B6F0682C4_1_1024.npy
what other pathological findings were seen in the excised breast samples? A. atypical lobular hyperplasia B. metastatic carcinoma C. extranodal extension D. columnar cell change
D. columnar cell change
TCGA-GM-A2DC-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A2DC-01Z-00-DX1.39F956BB-52D0-4385-9923-4D7D36D78862_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A2DC-01Z-00-DX1.39F956BB-52D0-4385-9923-4D7D36D78862_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A2DC-01Z-00-DX1.39F956BB-52D0-4385-9923-4D7D36D78862_1_1024.npy
what is the histologic grade of the invasive ductal carcinoma? A. grade 1 B. intermediate grade C. grade 2 D. grade 3
D. grade 3
TCGA-GM-A2DC-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A2DC-01Z-00-DX1.39F956BB-52D0-4385-9923-4D7D36D78862_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A2DC-01Z-00-DX1.39F956BB-52D0-4385-9923-4D7D36D78862_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-GM-A2DC-01Z-00-DX1.39F956BB-52D0-4385-9923-4D7D36D78862_1_1024.npy
what is the grade of the infiltrating ductal carcinoma? A. grade 1 B. grade 2 C. grade 3 D. grade 4
C. grade 3
TCGA-BH-A0B3-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B3-01Z-00-DX1.90CB0ED5-FBB7-4ABF-93A0-DD88D60D3D55_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B3-01Z-00-DX1.90CB0ED5-FBB7-4ABF-93A0-DD88D60D3D55_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B3-01Z-00-DX1.90CB0ED5-FBB7-4ABF-93A0-DD88D60D3D55_1_1024.npy
was lymphovascular invasion identified? A. yes B. no C. not mentioned D. unclear
B. no
TCGA-BH-A0B3-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B3-01Z-00-DX1.90CB0ED5-FBB7-4ABF-93A0-DD88D60D3D55_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B3-01Z-00-DX1.90CB0ED5-FBB7-4ABF-93A0-DD88D60D3D55_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B3-01Z-00-DX1.90CB0ED5-FBB7-4ABF-93A0-DD88D60D3D55_1_1024.npy
what is present in the nonneoplastic breast tissue? A. fibroadenoma B. fibrocystic changes C. intraductal papilloma D. granular cell tumor
B. fibrocystic changes
TCGA-BH-A0B3-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B3-01Z-00-DX1.90CB0ED5-FBB7-4ABF-93A0-DD88D60D3D55_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B3-01Z-00-DX1.90CB0ED5-FBB7-4ABF-93A0-DD88D60D3D55_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B3-01Z-00-DX1.90CB0ED5-FBB7-4ABF-93A0-DD88D60D3D55_1_1024.npy
what are the receptors negative in the invasive tumor? A. estrogen and progesterone B. progesterone and her-2/neu C. estrogen and her-2/neu D. her-2/neu and prolactin
A. estrogen and progesterone
TCGA-BH-A0B3-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B3-01Z-00-DX1.90CB0ED5-FBB7-4ABF-93A0-DD88D60D3D55_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B3-01Z-00-DX1.90CB0ED5-FBB7-4ABF-93A0-DD88D60D3D55_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B3-01Z-00-DX1.90CB0ED5-FBB7-4ABF-93A0-DD88D60D3D55_1_1024.npy
what was the surgical procedure performed on the patient? A. lumpectomy B. mastectomy C. biopsy D. radiation therapy
B. mastectomy
TCGA-BH-A1FN-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FN-01Z-00-DX1.CEE3C59B-6CF0-4D41-8334-6067BB5A8BF7_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FN-01Z-00-DX1.CEE3C59B-6CF0-4D41-8334-6067BB5A8BF7_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FN-01Z-00-DX1.CEE3C59B-6CF0-4D41-8334-6067BB5A8BF7_1_1024.npy
where were tissue samples taken from during the surgical procedure? A. left breast and axilla B. right breast and axilla C. left breast only D. right breast only
B. right breast and axilla
TCGA-BH-A1FN-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FN-01Z-00-DX1.CEE3C59B-6CF0-4D41-8334-6067BB5A8BF7_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FN-01Z-00-DX1.CEE3C59B-6CF0-4D41-8334-6067BB5A8BF7_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FN-01Z-00-DX1.CEE3C59B-6CF0-4D41-8334-6067BB5A8BF7_1_1024.npy
what is the diagnosis stated in the pathological slide? A. infiltrating lobular carcinoma B. ductal carcinoma in situ C. metastatic breast cancer D. infiltrating ductal carcinoma
D. infiltrating ductal carcinoma
TCGA-BH-A1FN-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FN-01Z-00-DX1.CEE3C59B-6CF0-4D41-8334-6067BB5A8BF7_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FN-01Z-00-DX1.CEE3C59B-6CF0-4D41-8334-6067BB5A8BF7_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FN-01Z-00-DX1.CEE3C59B-6CF0-4D41-8334-6067BB5A8BF7_1_1024.npy
what is the status of the margins mentioned in the slide? A. involved margins B. unclear margins C. grossly free margins D. close margins
C. grossly free margins
TCGA-BH-A1FN-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FN-01Z-00-DX1.CEE3C59B-6CF0-4D41-8334-6067BB5A8BF7_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FN-01Z-00-DX1.CEE3C59B-6CF0-4D41-8334-6067BB5A8BF7_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FN-01Z-00-DX1.CEE3C59B-6CF0-4D41-8334-6067BB5A8BF7_1_1024.npy
what is the final diagnosis of the patient's condition? A. triple-negative breast cancer B. lobular carcinoma in situ C. invasive lobular carcinoma D. intermediate grade invasive ductal carcinoma
D. intermediate grade invasive ductal carcinoma
TCGA-BH-A1FN-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FN-01Z-00-DX1.CEE3C59B-6CF0-4D41-8334-6067BB5A8BF7_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FN-01Z-00-DX1.CEE3C59B-6CF0-4D41-8334-6067BB5A8BF7_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A1FN-01Z-00-DX1.CEE3C59B-6CF0-4D41-8334-6067BB5A8BF7_1_1024.npy
what is the nottingham grade for the tumor? A. 5/9 B. 3/9 C. 6/9 D. 2/9
A. 5/9
TCGA-BH-A0B0-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B0-01Z-00-DX1.316D35DB-7F13-4AE5-82A7-5716D2519669_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B0-01Z-00-DX1.316D35DB-7F13-4AE5-82A7-5716D2519669_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B0-01Z-00-DX1.316D35DB-7F13-4AE5-82A7-5716D2519669_1_1024.npy
what is the tumor type? A. ductal adenocarcinoma B. lobular carcinoma C. squamous cell carcinoma D. fibroadenoma
A. ductal adenocarcinoma
TCGA-BH-A0B0-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B0-01Z-00-DX1.316D35DB-7F13-4AE5-82A7-5716D2519669_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B0-01Z-00-DX1.316D35DB-7F13-4AE5-82A7-5716D2519669_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B0-01Z-00-DX1.316D35DB-7F13-4AE5-82A7-5716D2519669_1_1024.npy
are the surgical margins involved by the invasive component? A. yes B. no C. not mentioned D. partially
B. no
TCGA-BH-A0B0-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B0-01Z-00-DX1.316D35DB-7F13-4AE5-82A7-5716D2519669_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B0-01Z-00-DX1.316D35DB-7F13-4AE5-82A7-5716D2519669_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-BH-A0B0-01Z-00-DX1.316D35DB-7F13-4AE5-82A7-5716D2519669_1_1024.npy
what was the nottingham grade of the infiltrating lobular carcinoma? A. grade i B. grade ii C. grade iii D. grade iv
A. grade i
TCGA-AR-A1AL-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A1AL-01Z-00-DX1.0970370F-6D4B-449A-AF33-76355DD99F91_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A1AL-01Z-00-DX1.0970370F-6D4B-449A-AF33-76355DD99F91_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A1AL-01Z-00-DX1.0970370F-6D4B-449A-AF33-76355DD99F91_1_1024.npy
were the surgical margins positive or negative for tumor? A. positive B. negative C. not mentioned D. inconclusive
B. negative
TCGA-AR-A1AL-01Z-00-DX1
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A1AL-01Z-00-DX1.0970370F-6D4B-449A-AF33-76355DD99F91_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A1AL-01Z-00-DX1.0970370F-6D4B-449A-AF33-76355DD99F91_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-AR-A1AL-01Z-00-DX1.0970370F-6D4B-449A-AF33-76355DD99F91_1_1024.npy
what is the histological grade of the invasive ductal carcinoma? A. nhg1 B. nhg2 C. nhg3 D. nhg4
C. nhg3
TCGA-D8-A1JJ-01Z-00-DX2
TCGA-BRCA
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JJ-01Z-00-DX2.7D20F308-7DC6-4367-9459-3AC4C654E7F7_0_1024.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JJ-01Z-00-DX2.7D20F308-7DC6-4367-9459-3AC4C654E7F7_1_512.npy
/bask/projects/p/phwq4930-renal-canc/Zeyu/WSI_Dataset/Conch/TCGA-BR/TCGA-D8-A1JJ-01Z-00-DX2.7D20F308-7DC6-4367-9459-3AC4C654E7F7_1_1024.npy